Research Progress, Bottlenecks and Strategies in the Plant Bioreactor

China Biotechnology

2009, Vol. 29

Issue (05): 104-110 DOI:

Research Progress, Bottlenecks and Strategies in the Plant Bioreactor

Download:

HTML

PDF(455KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract Past decade, plants as production systems for recombinant proteins has been actively investigated, and is one of the most active research fields in life sciences. Plants are attractive as protein factories because they with advantages of cost, scale, and safety, and emerge capability to produce pharmaceutical production with bioactivity proved by previously studies. The plantmade pharmaceuticals possess enormous viability for market and wide prospects for application. Based on those reasons, the rise of plant bioreactor was reviewed, and research advance on the expression systems and plantmade recombinant proteins was introduced. Bottleneck problems and adopted strategies using plant system to produce recombinant proteins and research hotspot in the near future were summarized, and prospect of plant bioreactor in future was described. Synchronously, some opinions including research progress of plant bioreactor, differences to foreign and strategies in the future were discussed.

Key words： plant bioreactor bottleneck strategy

Received: 31 December 2008 Published: 06 May 2009

Corresponding Authors: ZHAO Ling-xia

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIN Li-Xin- Diao-Ling-Xia

Cite this article:

JIN Li-Xin- Diao-Ling-Xia. Research Progress, Bottlenecks and Strategies in the Plant Bioreactor. China Biotechnology, 2009, 29(05): 104-110.

URL:

https://manu60.magtech.com.cn/biotech/ OR https://manu60.magtech.com.cn/biotech/Y2009/V29/I05/104

［1］ Pujol M,Gavilondo J,Ayala M,et al. Fighting cancer with plantexpressed pharmaceuticals. Trends in Biotechnology, 2007, 25(10): 455~459 ［2］ Lie’ nard D,Sourrouille C,Gomord V,et al. Pharming and transgenic plants. Biotechnology Annual Review, 2007, 13: 115~147 ［3］ Schillberg S,Fischer R,Emans N. Molecular farming of antibodies in plants. Naturwissenschaften,2003, 90:145~155 ［4］ Streatfield S J. Approaches to achieve highlevel heterologous protein production in plants. Plant Biotechnology Journal,2007,5:2~15 ［5］ Fischer R, Emans N. Molecular farming of pharmaceutical proteins. Transgenic Research, 2000,9（45）:279~299 ［6］ Ma J KC, Drake P M W, Christou P. The production of recombinant pharmaceutical proteins in plants. Nature Rev genetics, 2003, 794~805 ［7］ Lico C, Chen Q, Santi L. Viral vectors for production of recombinant proteins in plants. J Cell Physiol. 2008,216(2):366~377 ［8］ Chikwamba R K,Scott M P, Mejia L B,et al. Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc Natl Acad Sci USA, 2003,100:11127~11132 ［9］ Joensuu J J, Kotiaho M, Teeri T H, et al. Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETECneutralizing antibodies in mice. Transgenic Research, 2006, 15:359~373 ［10］ Brereton H M,Chamberlain D,Yang R,et al. Single chain antibody fragments for ocular use produced at high levels in a commercial wheat variety. J Biotechnol, 2007,129:539~546 ［11］ Nochi T,Takagi H,Yuki Y,et al. From the cover: Rice based mucosal vaccine as a global strategy for coldchain and needlefree vaccination. Proc Natl Acad Sci USA, 2007,104:10986~10991 ［12］ Carrillo C,Wigdorovitz A,Oliveros JC,et al. Protective immune response to footandmouth disease virus with VP1 expressed in transgenic plants. J Virol, 1998,72:1688~1690 ［13］ MarquetBlouin E,Bouche F B,Steinmetz A,et al. Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)derived measles virus hemagglutinin. Plant Mol Biol, 2003, 51:459~469 ［14］ Smart V,Foster P S,Rothenberg M E,et al. A plantbased allergy vaccine suppresses experimental asthma via an IFNgamma and CD4+CD45RB low T cell dependent mechanism. J Immunol, 2003, 171:2116~2126 ［15］ Watson J,Koya V,Leppla S H,et al. Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a nonfood/feed crop. Vaccine, 2004,22:4374~4384 ［16］ Huang Z,Elkin G,Maloney B J,et al. Viruslike particle expression and assembly in plants: Hepatitis B and Norwalk viruses. Vaccine,2005,23:1851~1858 ［17］ Huang L K,Liao S C,Chang C C,et al. Expression of avian reovirus sigma C protein in transgenic plants. J Virol Methods, 2006,134:217~222 ［18］ Sun H J, Cui M L, Ma B, et al. Functional expression of the tastemodifying protein, miraculin, in transgenic lettuce. FEBS Lett, 2006,580:620~626 ［19］ Moravec T,Schmidt M A,Herman E M,et al. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine, 2007, 25:1647~1657 ［20］ Youm J W,Won Y S,Jeon J H,et al. Oral immunogenicity of potatoderived HBsAg middle protein in BALB/cmice.Vaccine, 2007, 25:577~584 ［21］ Cox K M,Sterling J D,Regan J T,et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol,2006, 24:1591~1597 ［22］ Schaefer D G,Zryd J P. Efficient gene targeting in the moss Physcomitrella patens. Plant J, 1997,11:1195~1206 ［23］ LeonBanares R,GonzalezBallester D,Galvan A, et al. Transgenic microalgae as green cellfactories. Trends Biotechnol,2004, 22:45~52 ［24］ Barta A,Sommergruber K,Thompson D,et al. The expression of a nopaline synthase human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol, 1986, 6:347~357 ［25］ Chen Y H, Wang A X, Zhao L X,et al. Expression of thymosin alpha1 concatemer in transgenic tomato fruits. Biotechnol Appl Biochem, 2009,in press ［26］ Spo¨ k A. Molecular farming on the rise  GMO regulators still walking a tightrope. Trends in Biotechnology, 2007, 25: 74~82 ［27］ Hiatt A,Cafferkey R,Bowdish K.Production of antibodies in transgenic plants. Nature, 1989,342:76~78 ［28］ Fischer R,Twyman R M,Schillberg S. Production of antibodies in plants and their use for global health. Vaccine, 2003, 21:820~825 ［29］ Kn?blein J, Pujol M, Borroto C. Plantibodies for human therapeutic use. BioWorld Europe, 2007, 1:14~17 ［30］ Mason H S,Lam D M,Arntzen C J. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA, 1992, 89:11745~11749 ［31］ Mor T S,GomezLim M A,Palmer K E. Perspective: Edible vaccinesA concept coming of age. Trends Microbiol, 1998, 6:449~453 ［32］ Katsnelson A.USDA approves the first plantbased vaccine. Nature Biotechnology, 2006,24:234 ［33］ Golovkin M,Spitsin S,Andrianov V,et al. et al. Smallpox subunit vaccine produced in planta confers protection in mice. Proc Natl Acad Sci USA, 2007, 104:6864~6869 ［34］ Chichester J A,Musiychuk K,de la Rosa P,et al. Immunogenicity of a subunit vaccine against Bacillus anthracis. Vaccine, 2007,25:3111~3114 ［35］ Saejung W,Fujiyama K,Takasaki T,et al.Production of dengue 2 envelope domain III in plant using TMVbased vector system. Vaccine, 2007, 25:6646~6654 ［36］ Nemchinov L G,Natilla A.Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants. Protein Expr Purif, 2007, 56:153~159 ［37］ Pen J,van Ooyen A J,van den Elzen P J,et al. Direct screening for highlevel expression of an introduced alphaamylase gene in plants. Plant Mol Biol,1992,18:1133~1139 ［38］ Lamphear B J,Barker D K,Brooks C A,et al. Expression of the sweet protein brazzein in maize for production of a new commercial sweetener. Plant Biotechnol J, 2005, 3:103~114 ［39］ Clough R C,Pappu K,Thompson K,et al. Manganese peroxidase from the whiterot fungus Phanerochaete chrysosporium is enzymatically active and accumulates to high levels in transgenic maize seed. Plant Biotechnol J,2006,4:53~62 ［40］ Hood E E,Kusnadi A,Nikolov Z,et al. Molecular farming of industrial proteins from transgenic maize. Adv Exp Med Biol, 1999, 464:127~147 ［41］ Woodard S L,Mayor J M,Bailey M R,et al. Maize (Zea mays)derived bovine trypsin: Characterization of the first largescale, commercial protein product from transgenic plants. Biotechnol Appl Biochem,2003,38:123~130 ［42］ Huang J,Wu L,Yalda D,et al. Expression of functional recombinant human lysozyme in transgenic rice cell culture. Transgenic Research, 2002,11:229~239 ［43］ Humphrey B D,Huang N,Klasing K C. Rice expressing lactoferrin and lysozyme has antibioticlike properties when fed to chicks. J Nutr, 2002,132:1214~1218 ［44］ Gleba Y, Klimyuk V, Marillonnet S.Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology, 2007, 18:134~141 ［45］ Doran P M. Foreign protein degradation and instability in plants and plant tissue cultures. Trends in Biotechnology, 2006, 24(9): 426~432 ［46］ Nykiforuk C L,Boothe J G,Murray E W,et al. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnology Journal, 2006, 4:77~85 ［47］ Li Z T,Jayasankar S,Gray D J. Bidirectional duplex promoters with duplicated enhancers significantly increase transgene expression in grape and tobacco. Transgenic Research, 2004, 13: 143~154 ［48］ Gruis D F,Selinger D A,Curran J M,et al. Redundant proteolytic mechanisms process seed storage proteins in the absence of seedtype members of the vacuolar processing enzyme family of cysteine proteases. Plant Cell, 2002, 14: 2863~2882 ［49］ Van der Vyver C,Schneidereit J,Driscoll S,et al. Oryzacystatin I expression in transformed tobacco produces a conditional growth phenotype and enhances chilling tolerance. Plant Biotechnol J, 2003, 1: 101~112 ［50］ Michaud D, Anguenot R, Brunelle F. Method for increasing protein content in plant cells:U.S. Patent Application, 20050055746.2005 ［51］ Rivard D,Anguenot R,Brunelle F,et al. An inbuilt proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants. Plant Biotechnol J, 2006, 4:359~368 ［52］ Glenz K,Bouchon B,Stehle T,et al. Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat Biotechnol, 2006, 24(1):76~77 ［53］ Vidi P A,Kessler F,Bréhélin C. Plastoglobules: a new address for targeting recombinant proteins in the chloroplast. BMC Biotechnology, 2007, 7:4 ［54］ Giritch A,Marillonnet S,Engler C,et al. Rapid highyield expression of fullsize IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA, 2006,103:14701~14706 ［55］ Strasser R,Stadlmann J,Svoboda B,et al. Molecular basis of Nacetylglucosaminyl transferase I deficiency in Arabidopsis thaliana plants lacking complex Nglycans. Biochem J, 2005, 387:385~391 ［56］ Nuttall J,Ma J K,Frigerio L. A functional antibody lacking Nlinked glycans is efficiently folded, assembled and secreted by tobacco mesophyll protoplasts. Plant Biotechnol J, 2005, 3: 497~504 ［57］ Rodriguez M,Ramirez N I,Ayala M,et al.Transient expression in tobacco leaves of an aglycosylated recombinant antibody against the epidermal growth factor receptor. Biotechnol Bioeng,2005, 89:188~194 ［58］ Misaki R,Kimura Y,Palacpac N Q,et al. Plant cultured cells expressing human beta1,4galactosyltransferase secrete glycoproteins with galactoseextended Nlinked glycans. Glycobiology, 2003,13:199~205 ［59］ Koprivova A,Stemmer C,Altmann F,et al. Targeted knockouts of Physcomitrella lacking plantspecific immunogenic Nglycans. Plant Biotechnol J, 2004, 2:517~523 ［60］ Downing W H,Galpin J D,Clemens S,et al. Synthesis of enzymatically active human alphaLiduronidase in Arabidopsis cgl (complex glycandeficient) seeds. Plant Biotechnol J, 2006, 4:169~182 ［61］ Palacpac N Q,Yoshida S,Sakai H,et al. Stable expression of human beta1,4galactosyltransferase in plant cells modifies Nlinked glycosylation patterns. Proc Natl Acad Sci USA, 1999, 96: 4692~4697 ［62］ Fujiyama K,Palacpac N Q,Sakai H,et al. In vivo conversion of a glycan to human compatible type by transformed tobacco cells. Biochem Biophys Res Commun, 2001,289:553~557 ［63］ Bakker H,Rouwendal G J,Karnoup A S,et al. An antibody produced in tobacco expressing a hybrid β1,4galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci USA, 2006, 103:7577~7582 ［64］ SaintJoreDupas C,Faye L,Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol, 2007, 25:317~323 ［65］ Kusnadi A R,Hood E E,Witcher D R,et al. Production and purification of two recombinant proteins from transgenic corn. Biotechnol Prog, 1998,14:149~155 ［66］ Schillberg S,Twyman R M,Fischer R. Opportunities for recombinant antigen and antibody expression in transgenic plantstechnology assessment. Vaccine, 2005, 23:1764~1769 ［67］ Azeez G. Ampicillin threat leads to wider transgene concern. Nature,2005, 435:561 ［68］ Kok E J,Keijer J,Kleter G A,et al.Comparative safety assessment of plantderived foods. Regulatory Toxicology and Pharmacology, 2008, 50: 98~113 ［69］ Thompson P B,Hannah W. Food and Agricultural Biotechnology: A Summary and Analysis of Ethical Concerns. Adv Biochem Engin/Biotechnol, 2008, 111:229~264 ［70］ Delaney B,Astwood J D,Cunny H,et al. et al. Evaluation of protein safety in the context of agricultural biotechnology. Food and Chemical Toxicology,2008,46: S71~S97 ［71］ Williams C G. The fit between organic and pharma crops in North Carolina. Nature Biotechnology, 2007, 25:166~167 ［72］ Editorial. Don't rely on Uncle Sam. Nature, 2005, 434:807 ［73］ Dong J L,Liang BG,Jin Y S,et al. Oral immunization with pBsVP6 transgenic alfalfa protects mice against rotavirus infection. Virology, 2005, 339 (9):153~163

No related articles found!

Viewed

Full text

Abstract

Cited

Shared

Discussed